Takeda’s Combo Duetact Will Launch Later This Year For Type 2 Diabetes
This article was originally published in The Pink Sheet Daily
Executive Summary
Takeda's existing Actos sales force will detail the pioglitazone and glimepiride combination therapy to primary care physicians.